Zi Long Qian
Chief Executive Officer chez SHENZHEN KINGSINO TECHNOLOGY CO.,LTD.
Fortune : 204 376 $ au 31/03/2024
Profil
Zi Long Qian is currently the Director at Wuhan Huayang Animal Pharmaceutical Co., Ltd.
and the General Manager at Shenzhen Kingsino Technology Co., Ltd.
He has an undergraduate degree from China University of Geosciences and an MBA from Sun Yat-Sen University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/08/2023 | 292 500 ( 0,05% ) | 204 376 $ | 31/03/2024 |
Postes actifs de Zi Long Qian
| Sociétés | Poste | Début |
|---|---|---|
| SHENZHEN KINGSINO TECHNOLOGY CO.,LTD. | Chief Executive Officer | 28/10/2022 |
Wuhan Huayang Animal Pharmaceutical Co., Ltd.
 Wuhan Huayang Animal Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Huayang Animal Pharmaceutical Co., Ltd. is a private company that manufactures and sells veterinary drugs, aquatic feed drug additives, and aquaculture fertilizer. The company is based in Wuhan, China. Wuhan Huayang Animal Pharmaceutical Co. was acquired by Wuhan Huayang Animal Pharmaceutical Co. Ltd. /Sun/ from Shenzhen Kingsino Technology Co., Ltd. on April 16, 2022 for $24.21 million. The Chinese company was founded in 2000. The CEO is Jin Lin Zhang. | Director/Board Member | - |
Formation de Zi Long Qian
| China University of Geosciences | Undergraduate Degree |
| Sun Yat-Sen University | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| SHENZHEN KINGSINO TECHNOLOGY CO.,LTD. | Process Industries |
| Entreprise privées | 1 |
|---|---|
Wuhan Huayang Animal Pharmaceutical Co., Ltd.
Wuhan Huayang Animal Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Wuhan Huayang Animal Pharmaceutical Co., Ltd. is a private company that manufactures and sells veterinary drugs, aquatic feed drug additives, and aquaculture fertilizer. The company is based in Wuhan, China. Wuhan Huayang Animal Pharmaceutical Co. was acquired by Wuhan Huayang Animal Pharmaceutical Co. Ltd. /Sun/ from Shenzhen Kingsino Technology Co., Ltd. on April 16, 2022 for $24.21 million. The Chinese company was founded in 2000. The CEO is Jin Lin Zhang. | Health Technology |
